DERM
USDJourney Medical Corporation Common Stock
$9.000+0.590 (7.015%)
即時價格
Healthcare
Drug Manufacturers - Specialty & Generic
美國
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$8.410
最高
$9.010
最低
$8.260
交易量
0.22M
公司基本面
市值
236.8M
行業
Drug Manufacturers - Specialty & Generic
國家
United States
交易統計
平均交易量
0.16M
交易所
NCM
貨幣
USD
52週範圍
最低 $3.535當前 $9.000最高 $9.01
相關新聞
GlobeNewswire
Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference
FDA-approved Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) is available in the United States for the treatment of inflammatory lesions of rosacea
查看更多
GlobeNewswire
Journey Medical Corporation to Participate in October 2025 Investor Conferences
SCOTTSDALE, Ariz., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation ("Journey Medical" or "the Company") (NASDAQ:DERM), a commercial-stage pharmaceutical company primarily focused on selling and marketing
查看更多
相關股票
保持更新
設定價格提醒，獲取AI分析更新和即時市場新聞。